Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
L

LSL Pharma Group Inc
XTSX:LSL

Watchlist Manager
LSL Pharma Group Inc
XTSX:LSL
Watchlist
Price: 0.495 CAD -1% Market Closed
Market Cap: CA$62.7m
Write Note Create Alert Ask AI

Gross Margin

29.7%
Current
Improving
by 6.4%
vs 3-y average of 23.3%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
29.7%
=
Gross Profit
CA$8m
/
Revenue
CA$26.8m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
29.7%
=
Gross Profit
CA$8m
/
Revenue
CA$26.8m

Peer Comparison

Country Company Market Cap Gross
Margin
CA
LSL Pharma Group Inc
XTSX:LSL
60m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
965.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
594B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
395.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
291.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
242.5B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
303.7B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...

Market Distribution

In line with most companies in Canada
Percentile
43rd
Based on 4 108 companies
43rd percentile
29.7%
Low
-10 058.3% — 20.4%
Typical Range
20.4% — 50.5%
High
50.5% — 717.4%
Distribution Statistics
Canada
Min -10 058.3%
30th Percentile 20.4%
Median 33.6%
70th Percentile 50.5%
Max 717.4%

Other Profitability Ratios

LSL Pharma Group Inc
Glance View

Market Cap
62.7m CAD
Industry
N/A

LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm specializes in the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms. The firm is also engaged in selling sterile ophthalmic pharmaceutical products.

LSL Intrinsic Value
0.443 CAD
Overvaluation 10%
Intrinsic Value
Price
L
What is Intrinsic Value?

See Also

Summary
LSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
LSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LSL stock valuation using valuation multiples.
Wall Street Estimates
LSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
29.7%
=
Gross Profit
CA$8m
/
Revenue
CA$26.8m
What is LSL Pharma Group Inc's current Gross Margin?

The current Gross Margin for LSL Pharma Group Inc is 29.7%, which is above its 3-year median of 23.3%.

How has Gross Margin changed over time?

Over the last 3 years, LSL Pharma Group Inc’s Gross Margin has increased from 1.7% to 29.7%. During this period, it reached a low of 1.7% on Mar 3, 2023 and a high of 31.2% on Mar 31, 2025.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.